# Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)

> **NCT01293981** · — · TERMINATED · sponsor: **Alphatec Spine, Inc.** · enrollment: 6 (actual)

## Conditions studied

- Lumbar Degenerative Disc Disease

## Interventions

- **BIOLOGICAL:** PureGen Osteoprogenitor Cell Allograft

## Key facts

- **NCT ID:** NCT01293981
- **Lead sponsor:** Alphatec Spine, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2012-01
- **Final completion:** —
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Product no longer on the market
- **Last updated:** 2016-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01293981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01293981, "Radiographic and Clinical Outcomes of PureGen in Posterior Lumbar (PLIF) and Transforaminal Interbody Fusion (TLIF)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01293981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*